{
    "organizations": [],
    "uuid": "1a695ac5d0b9d314164d054553cdd65dfd7dd8f3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shanghai-haohai-biological-technol/brief-shanghai-haohai-biological-technology-posts-fy-profit-of-rmb372-4-mln-idUSFWN1R812Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Shanghai Haohai Biological Technology Posts FY Profit Of RMB372.4 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Shanghai Haohai Biological Technology Co Ltd:\n* FY AGGREGATE REVENUE RMB1,344.86 MILLION, UP 58.0% * FY PROFIT ‍ATTRIBUTABLE RMB372.4 MILLION VERSUS RMB305.1 MILLION\n* ‍PROPOSED TO DECLARE A FINAL DIVIDEND OF RMB0.50 PER SHARE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-27T08:32:00.000+03:00",
    "crawled": "2018-03-27T12:14:40.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "shanghai",
        "haohai",
        "biological",
        "technology",
        "co",
        "ltd",
        "fy",
        "aggregate",
        "revenue",
        "million",
        "fy",
        "profit",
        "million",
        "versus",
        "million",
        "declare",
        "final",
        "dividend",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}